Moderna (MRNA) IV into BARDA additional $472M commitment

Moderna (NASDAQ: MRNA) Moderna (NASDAQ: MRNA) July weekly call option implied volatility is at 97, August is at 102; compared to its 52-week range of 51 to 172 into Biomedical Advanced Research and Development Authority, or BARDA, making an additional commitment of up to $472M to support late stage clinical development including the expanded Phase 3 study of the company's mRNA vaccine candidate against COVID-19.

You May Also Be Interested In

• Micron Technology (MU) call put ratio 1.2 calls to 1 put into quarter results
• Quantum Computing Inc (QUBT) call put ratio 6.5 calls to 1 put with a focus on June 26 weekly 12.50 calls as share price up 3.1%
• Ross Stores (ROST) call put ratio 1 call to 1 put as share price down 3%